Chris Mancill | Senior Vice President, Head, US Market Access
AstraZeneca

Chris is the Senior Vice President and Head of US Market Access at AstraZeneca. In this role, he oversees efforts to communicate the value proposition of AstraZeneca's product portfolio to payers, the US government, and other key access stakeholders. Additionally, he leads initiatives to develop innovative solutions that ensure appropriate patient access to the company’s products. Prior to joining AstraZeneca, Chris held senior leadership positions in market access at Bristol Myers Squibb, including serving as the Senior Vice President and Head of Global Market Access, Pricing, and Value Demonstration and earlier as Senior Vice President, US Market Access & Pricing. He has a proven track record of success in market access across both domestic and international markets, with over three decades of experience in the healthcare industry. Throughout his career, Chris has held leadership roles in the innovative biopharmaceutical industry, including at Amgen, Merck Serono, and MorphoSys (acquired by Novartis) and he has also served two terms on the Board of the National Pharmaceutical Council. In his personal time, Chris serves as a patient advocate for persons living with facioscapulohumeral muscular dystrophy (FSHD) and is a Board Member for the FSHD Society.